Abstract
As the prevalence of dementia in the UK continues to rise, there is a desperate clinical need for new therapies. Many drug candidates that have shown promise in early clinical trials have failed in late‐phase studies, but novel approaches, such as combination therapy and earlier diagnosis and intervention, may offer more hope for the future.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
